ReCAP

Maintenance Therapy for Urothelial Carcinoma Dr Scott Tagawa discusses maintenance therapies for urothelial carcinoma, including cisplatin, avelumab, pembrolizumab, and the newly approved combination enfortumab vedotin plus pembrolizumab.
June 01, 2023
Early Diagnosis and Treatment in Alzheimer's Disease Breakthroughs that aid in early detection of Alzheimer's disease as well as the development of new disease-modifying therapies are poised to modify the course of Alzheimer's disease.
June 01, 2023
Efficacy and Safety Learnings From COVID-19 Vaccine Trials Dr Karine Lacombe reviews global trial data on vaccine safety and efficacy against SARS-CoV-2 variants. She compares vaccine platforms, addresses rare adverse events, and discusses cellular immunity.
June 01, 2023
Survivorship in Veterans: Prostate Cancer Prostate cancer experts share insights on optimal delivery of prostate cancer survivorship care to US veterans in an effort to alleviate psychological trauma and prevent treatment regret.
June 01, 2023
Long-Term Effects of COVID-19 Prof Matteo Bassetti discusses the long-term health effects of COVID-19, such as the multisystem condition known as long COVID, and the role of immunization in reducing the risk for COVID sequelae.
May 31, 2023
Risk Factors for Severe COVID-19 Prof Matteo Bassetti discusses the role of immunization in protecting those most at risk for severe COVID-19, including older adults, patients with comorbidities, and the immunocompromised.
May 31, 2023
Lung Fibrosis and Idiopathic Pulmonary Fibrosis Dr Imre Noth discusses why slowing lung fibrosis in patients with idiopathic pulmonary fibrosis improves prognosis and reports on therapies that preserve lung function and slow disease progression.
May 26, 2023
Rapid Symptom Improvement in Major Depressive Disorder Two unmet needs in major depressive disorder are options for patients who do not respond to standard medicine and faster onset of effect. Dr Michael Thase discusses new drugs that address these needs.
May 26, 2023
Treating Heart Failure in Patients With T2D and Renal Dysfunction Dr Larry Allen discusses novel therapies that slow heart failure progression in patients with type 2 diabetes and renal dysfunction.
May 25, 2023
Diversity, Equity, and Inclusion in Colorectal Cancer Treatment Racial disparities affect colorectal cancer outcomes, from screening to treatment and mortality. Dr Renee Williams discusses what physicians can do to modify these trends and increase health equity.
May 24, 2023
Combination Therapies for Patients With Type 2 Diabetes Dr Chika Anekwe discusses when to combine antidiabetic therapies that have differing mechanisms, advantages of combination therapy, and the newest therapeutic options.
May 17, 2023
Inherited Retinal Diseases: Early Signs and Treatment New therapies to treat inherited retinal diseases are in development in the wake of excitement over the benefits some patients are receiving from the one approved medication in this setting.
May 11, 2023
Reducing Hospitalization in Heart Failure A new class of drugs and improvements in patient management have led to a reduction of recurrent readmissions for heart failure, according to Dr Clyde Yancy of Northwestern University.
May 09, 2023
Managing Iron Deficiency in Patients With Heart Failure Dr Theresa McDonagh highlights iron supplementation trials examining the effects of intravenous ferric carboxymaltose, as well as new ESC guidelines for iron deficiency, in patients with heart failure.
May 08, 2023
Selecting Biologics in Active Psoriatic Arthritis Active psoriatic arthritis is highly heterogeneous and linked to multiple conditions. Prof Laura Coates explains how biologics can be individualized to a patient's comorbidities to improve outcomes.
May 08, 2023
Non-Insulin Treatment Adherence in Type 2 Diabetes Non-insulin treatment adherence is a challenge for many patients with type 2 diabetes. Dr Anne Peters offers clinicians tips for overcoming some of the barriers.
May 02, 2023
Managing Patients With Obesity and Impaired Renal Function Dr Alex Chang discusses the importance of weight reduction in patients with obesity and impaired renal function as well as available therapies that address both conditions.
May 01, 2023
Obesity Management in Youth-Onset Type 2 Diabetes Current treatment and behavioral guidelines for youth-onset type 2 diabetes and obesity management, including liraglutide, dulaglutide, and exenatide, are discussed by Dr Amy S. Shah.
May 01, 2023
Endocrine Therapy Resistance in HR+/HER2- Breast Cancer Oncologist Jennifer Litton discusses endocrine therapy and CDK4/6 inhibitors in hormone receptor–positive breast cancer, drivers of endocrine resistance, and the role of genetic testing in treatment selection.
May 01, 2023
Emerging Therapies for Alzheimer's Disease Dr Pierre Tariot of the Banner Alzheimer's Institute reviews data on new and emerging therapies for Alzheimer's disease, including recently approved anti-amyloid therapies.
April 28, 2023